{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:20:14Z","timestamp":1794781214628,"version":"4.9.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2025\/00681-5"],"award-info":[{"award-number":["2025\/00681-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/15854-0"],"award-info":[{"award-number":["2024\/15854-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/10265-8"],"award-info":[{"award-number":["2021\/10265-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1053\/j.semnuclmed.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:55:04Z","timestamp":1789678504000},"page":"1052-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The value of 18F-fluoride PET in bone metastases: An overview"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1544-8591","authenticated-orcid":false,"given":"Caroline","family":"Torricelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Nogueira-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-5943","authenticated-orcid":false,"given":"Elba","family":"Etchebehere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0001","series-title":"Abeloff\u2019s Clinical Oncology","first-page":"809","article-title":"Bone Metastases","author":"Coleman","year":"2020"},{"issue":"20","key":"10.1053\/j.semnuclmed.2026.08.011_bib0002","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2019.05.003","article-title":"Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody","volume":"76","author":"von Moos","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.actbio.2019.04.008","article-title":"18F-fluoride as a prognostic indicator of bone regeneration","volume":"90","author":"Mathavan","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0005","first-page":"332","article-title":"Fluorine-18: a new isotope for bone scanning","volume":"3","author":"Blau","year":"1962","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-2998(72)80005-9","article-title":"18F-fluoride for bone imaging","volume":"2","author":"Blau","year":"1972","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004728-199301000-00005","article-title":"Whole body skeletal imaging with [18F]fluoride ion and PET","volume":"17","author":"Hoh","year":"1993","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0008","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/snuc.2001.18742","article-title":"Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate","volume":"31","author":"Blake","year":"2001","journal-title":"Semin Nucl Med"},{"issue":"15","key":"10.1053\/j.semnuclmed.2026.08.011_bib0009","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1039\/C6CS00492J","article-title":"Fluorine-18 labelled building blocks for PET tracer synthesis","volume":"46","author":"van der Born","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0010","doi-asserted-by":"crossref","DOI":"10.23736\/S1824-4785.23.03534-3","article-title":"Role of 18F-NaF PET\/CT in bone metastases","volume":"67","author":"Zhang-Yin","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcdb.2022.11.002","article-title":"Epigenetic regulation of bone remodeling and bone metastasis","volume":"154","author":"Sharma","year":"2024","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0012","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100597","article-title":"The osteoblast in regulation of tumor cell dormancy and bone metastasis","volume":"45","author":"Zarrer","year":"2024","journal-title":"J Bone Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0014","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.semnuclmed.2024.09.005","article-title":"18F-Fluoride PET\/CT\u2014updates","volume":"54","author":"Nogueira-Lima","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.semnuclmed.2014.07.008","article-title":"Sodium 18F-Fluoride PET\/CT of Bone, Joint, and Other Disorders","volume":"45","author":"Jadvar","year":"2015","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2967\/jnmt.119.234336","article-title":"18 F-sodium fluoride PET: history, technical feasibility, mechanism of action, normal biodistribution, and diagnostic performance in bone metastasis detection compared with other imaging modalities","volume":"48","author":"Ahuja","year":"2020","journal-title":"J Nucl Med Technol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0017","first-page":"1301","article-title":"Studies of skeletal tracer kinetics. I. Digital-computer solution of a five-compartment model of [18F] fluoride kinetics in humans","volume":"19","author":"Charkes","year":"1978","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0018","first-page":"633","article-title":"Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET","volume":"33","author":"Hawkins","year":"1992","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0019","first-page":"1970","article-title":"Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET","volume":"38","author":"Schiepers","year":"1997","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0020","first-page":"435","article-title":"Factors Affecting Uptake of NaF-18 by the Normal Skeleton","volume":"6","author":"Win","year":"2014","journal-title":"J Clin Med Res"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.08.011_bib0021","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/MNM.0000000000000891","article-title":"Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET\/CT","volume":"39","author":"Ayubcha","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0022","doi-asserted-by":"crossref","DOI":"10.1097\/MNM.0000000000002134","article-title":"Evaluation of physiological bone metabolic activity in the spine with 18F-fluorodeoxyglucose and 18F-sodium fluoride PET: associations with degenerative risk factors","author":"Patil","year":"2026","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13550-023-00969-4","article-title":"18F]Fluoride uptake in various bone types and soft tissues in rat","volume":"13","author":"Savisto","year":"2023","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0024","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18 F-fluoride: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","article-title":"Molecular mechanisms of Bone 18 F-NaF deposition","volume":"51","author":"Czernin","year":"2010","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0026","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2967\/jnumed.110.082263","article-title":"SNM practice guideline for sodium 18 F-fluoride PET\/CT bone scans 1.0","volume":"51","author":"Segall","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0027","series-title":"Fluoride Toxicity in Animals","first-page":"21","article-title":"Chapter 3 \u2013 fluoride kinetics and metabolism","author":"Ranjan","year":"2015"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0028","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2967\/jnumed.119.234260","article-title":"Molecular imaging of bone metastases and their response to therapy","volume":"61","author":"Cook","year":"2020","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1102\/1470-7330.2010.0022","article-title":"Review article: PET and PET\/CT imaging of skeletal metastases","volume":"10","author":"Cook","year":"2010","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2011.09.053","article-title":"Clinical utility of 18F-fluoride PET\/CT in benign and malignant bone diseases","volume":"50","author":"Li","year":"2012","journal-title":"Bone"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0031","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12149-019-01343-y","article-title":"18F-NaF-PET\/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies","volume":"33","author":"Sheikhbahaei","year":"2019","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RLU.0000000000000592","article-title":"Performance of 18F-fluoride PET or PET\/CT for the detection of bone metastases","volume":"40","author":"Shen","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.59667\/sjoranm.v25i1.16","article-title":"The diagnostic accuracy of 18F-NaF PET\/CT versus 99mTc bone scintigraphy for detection of skeletal metastases: a systematic review and meta-analysis","volume":"25","author":"Quazi","year":"2025","journal-title":"Swiss J Radiol Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0034","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00259-022-06028-9","article-title":"EANM practice guideline for quantitative SPECT-CT","volume":"50","author":"Dickson","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/0284186X.2015.1027411","article-title":"Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18 F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial","volume":"55","author":"Jambor","year":"2016","journal-title":"Acta Oncol (Madr)"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0036","first-page":"218","article-title":"Diagnostic test accuracy study of 18F-sodium fluoride PET\/CT, 99mTc-labelled diphosphonate SPECT\/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer","volume":"7","author":"Fonager","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0037","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00256-019-03230-z","article-title":"Comparison of PSMA-PET\/CT, choline-PET\/CT, NaF-PET\/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis","volume":"48","author":"Zhou","year":"2019","journal-title":"Skeletal Radiol"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0038","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-026-08009-8","article-title":"Does 18F-sodium fluoride PET\/CT have a role in the assessment of response to 223Ra therapy in men with prostatic bone metastases?","author":"Blake","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.08.011_bib0039","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2967\/jnumed.115.156026","article-title":"Determination of skeletal tumor burden on 18 F-fluoride PET\/CT","volume":"56","author":"Rohren","year":"2015","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2967\/jnumed.115.158626","article-title":"Prognostic factors in patients treated with 223 Ra: the role of skeletal tumor burden on baseline 18 F-Fluoride PET\/CT in predicting overall survival","volume":"56","author":"Etchebehere","year":"2015","journal-title":"J Nucl Med"},{"issue":"22","key":"10.1053\/j.semnuclmed.2026.08.011_bib0041","doi-asserted-by":"crossref","first-page":"36001","DOI":"10.18632\/oncotarget.16418","article-title":"18F-Fluoride PET\/CT tumor burden quantification predicts survival in breast cancer","volume":"8","author":"Brito","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0042","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/RLU.0000000000001118","article-title":"Skeletal tumor burden on baseline 18F-fluoride PET\/CT predicts bone marrow failure after 223ra therapy","volume":"41","author":"Etchebehere","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0043","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacr.2010.02.015","article-title":"ACR appropriateness criteria\u00ae on metastatic bone disease","volume":"7","author":"Roberts","year":"2010","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0044","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13139-020-00666-3","article-title":"Comparison of 18F-NaF PET\/CT with other imaging methods in the detection of bone metastases in patients with medullary thyroid cancer: a report of a series of 31 cases","volume":"54","author":"Ueda","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.08.011_bib0045","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejrad.2011.12.020","article-title":"Detection of metastatic bone lesions in breast cancer patients: fused 18F-Fluoride-PET\/MDCT has higher accuracy than MDCT. preliminary experience","volume":"81","author":"Piccardo","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0046","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semnuclmed.2024.10.008","article-title":"Diagnosing bone metastases in breast cancer: a systematic review and network meta-analysis on diagnostic test accuracy studies of 2-[18F]FDG-PET\/CT, 18F-NaF-PET\/CT, MRI, contrast-enhanced ct, and bone scintigraphy","volume":"55","author":"Gerke","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0047","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jmri.22608","article-title":"Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis","volume":"34","author":"Wu","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0048","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00330-002-1344-z","article-title":"Whole-body MRI using a rolling table platform for the detection of bone metastases","volume":"12","author":"Lauenstein","year":"2002","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0049","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/ajr.177.1.1770229","article-title":"Whole-body mr imaging for detection of bone metastases in children and young adults","volume":"177","author":"He","year":"2001","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2214\/AJR.11.8351","article-title":"Whole-body diffusion-weighted mri compared with 18 F-NaF PET\/CT for detection of bone metastases in patients with high-risk prostate carcinoma","volume":"199","author":"Mosavi","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0051","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1148\/rg.210090","article-title":"Common skeletal neoplasms and nonneoplastic lesions at 18 F-FDG PET\/CT","volume":"42","author":"Cheung","year":"2022","journal-title":"RadioGraphics"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0052","first-page":"1","article-title":"Comparison of 18 F-NaF PET\/CT and 18 F-FDG PET\/CT for detection of skull-base invasion and osseous metastases in nasopharyngeal carcinoma","volume":"2018","author":"Zhang","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.08.011_bib0053","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1097\/RLU.0b013e3182815f64","article-title":"Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET\/CT, 18F FDG PET\/CT and whole-body mri for detection of skeletal metastases","volume":"38","author":"Iagaru","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0054","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3892\/ol.2024.14679","article-title":"Diagnostic performance of 18 F-FDG PET\/CT vs. 18 F-NaF PET\/CT in breast cancer with bone metastases: an indirect comparative meta-analysis","volume":"28","author":"Hu","year":"2024","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00259-018-4223-9","article-title":"Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET\/CT with whole-body MRI with diffusion-weighted imaging","volume":"46","author":"Azad","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"04","key":"10.1053\/j.semnuclmed.2026.08.011_bib0056","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3413\/Nukmed-0727-15-02","article-title":"18F-FDG PET\/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET\/CT","volume":"54","author":"Piccardo","year":"2015","journal-title":"Nuklearmedizin"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0057","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41585-022-00618-w","article-title":"The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer","volume":"19","author":"Wang","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0058","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2967\/jnumed.117.207373","article-title":"A prospective comparison of 18 F-Sodium fluoride PET\/CT and PSMA-Targeted 18 F-DCFBC PET\/CT in metastatic prostate cancer","volume":"59","author":"Harmon","year":"2018","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0059","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00259-018-4058-4","article-title":"Prospective comparison of 68Ga-PSMA PET\/CT, 18F-sodium fluoride PET\/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer","volume":"45","author":"Zacho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"102","key":"10.1053\/j.semnuclmed.2026.08.011_bib0060","doi-asserted-by":"crossref","first-page":"37676","DOI":"10.18632\/oncotarget.26481","article-title":"A comparison of prostate cancer bone metastases on 18F-sodium fluoride and prostate specific membrane antigen (18F-PSMA) PET\/CT: discordant uptake in the same lesion","volume":"9","author":"Harmon","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0061","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/la702753j","article-title":"Complexes of DOTA\u2212bisphosphonate conjugates: probes for determination of adsorption capacity and affinity constants of hydroxyapatite","volume":"24","author":"Vitha","year":"2008","journal-title":"Langmuir"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0062","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12149-019-01348-7","article-title":"Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET\/CT diagnosis of bone diseases","volume":"33","author":"Khawar","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1027792","article-title":"Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1428498","article-title":"Prospective comparison of 68Ga-DOTA-ibandronate and bone scans for detecting bone metastases in breast cancer","volume":"14","author":"Xiang","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0065","article-title":"The performance of 68Ga-DOTA-IBA PET\/CT for detecting bone metastases compared with 99mTc-MDP bone scintigraphy","volume":"16","author":"Lin","year":"2026","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1364311","article-title":"Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis","volume":"14","author":"Deng","year":"2024","journal-title":"Front Oncol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0067","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","article-title":"Current concepts in 68 Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies","volume":"58","author":"Bodei","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0068","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5603\/NMR.2011.0004","article-title":"The diagnostic role of 68Ga-DOTATATE PET\/CT in the detection of neuroendocrine tumours","volume":"14","author":"\u0141api\u0144ska","year":"2011","journal-title":"Nucl Med Rev"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0069","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-3919.125762","article-title":"68 Ga-DOTATATE positron emission tomography\/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors","volume":"29","author":"Goel","year":"2014","journal-title":"Indian J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13139-018-0527-8","article-title":"Bone and calcified soft tissue metastases of medullary thyroid carcinoma better characterized on 18f-fluoride pet\/ct than on 68Ga-dotatate PET\/CT","volume":"52","author":"Duarte","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0071","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/RLU.0000000000002163","article-title":"Brain metastasis of medullary thyroid carcinoma without macroscopic calcification detected first on 68Ga-dotatate and then on 18f-fluoride PET\/CT","volume":"43","author":"Duarte","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"01","key":"10.1053\/j.semnuclmed.2026.08.011_bib0072","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/1450-1147.172307","volume":"16","author":"Ranade","year":"2017","journal-title":"World J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.08.011_bib0073","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.crad.2018.12.011","article-title":"The diagnostic performance of 18F-fluoride PET\/CT in bone metastases detection: a meta-analysis","volume":"74","author":"Liu","year":"2019","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0074","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2967\/jnumed.114.150391","article-title":"18 F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the national oncologic PET registry","volume":"56","author":"Hillner","year":"2015","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0076","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-015-3138-y","article-title":"18F-NaF PET\/CT: EANM procedure guidelines for bone imaging","volume":"42","author":"Beheshti","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0077","series-title":"Bone Metastases from Prostate Cancer","first-page":"223","article-title":"Approaches for assessment of response of bone metastases to therapies","author":"Bombardieri","year":"2017"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0078","series-title":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer","year":"2026"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0079","series-title":"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer","year":"2026"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0080","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.21037\/tcr-23-817","article-title":"Comparison of the diagnostic value of 18F-NaF PET\/CT and 99mTc-MDP SPECT for bone metastases: a systematic review and meta-analysis","volume":"12","author":"Fan","year":"2023","journal-title":"Transl Cancer Res"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0081","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2967\/jnumed.125.270822","article-title":"18 F-PSMA PET\/CT versus 18 F-NaF PET\/CT for staging and treating newly diagnosed high-risk prostate cancer: a prospective single-center study","volume":"66","author":"Madsen","year":"2025","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0082","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40336-020-00363-3","article-title":"Comparison between 18F-FDG and 18F-NaF PET imaging for assessing bone metastases in breast cancer patients: a literature review","volume":"8","author":"Taralli","year":"2020","journal-title":"Clin Transl Imaging"},{"issue":"31","key":"10.1053\/j.semnuclmed.2026.08.011_bib0083","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1200\/JCO.22.00400","article-title":"Clinical validity of 16\u03b1-[ 18 F]Fluoro-17\u03b2-estradiol positron emission tomography\/computed tomography to assess estrogen receptor status in newly diagnosed metastatic breast cancer","volume":"40","author":"van Geel","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0084","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s002560050340","article-title":"Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CT","volume":"27","author":"Petr\u00e9n-Mallmin","year":"1998","journal-title":"Skeletal Radiol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0085","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.1999.17.8.2381","article-title":"Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography","volume":"17","author":"Schirrmeister","year":"1999","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0086","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.08.011_bib0087","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00259-009-1181-2","article-title":"Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET\/CT","volume":"36","author":"Kr\u00fcger","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0088","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/jcm13020569","article-title":"Tumor burden of iodine-avid bone metastatic thyroid cancer identified via 18f-sodium fluoride PET\/CT imaging","volume":"13","author":"Nappi","year":"2024","journal-title":"J Clin Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.08.011_bib0089","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/105072501750362754","article-title":"Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with f-18 sodium fluoride positron emission tomography","volume":"11","author":"Schirrmeister","year":"2001","journal-title":"Thyroid"},{"issue":"1034","key":"10.1053\/j.semnuclmed.2026.08.011_bib0090","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130444","article-title":"Comparison of 18 F-fluoride PET\/CT, 18 F-FDG PET\/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study","volume":"87","author":"Ota","year":"2014","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0091","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3348\/kjr.2016.17.2.281","article-title":"F-18 sodium fluoride positron emission tomography\/computed tomography for detection of thyroid cancer bone metastasis compared with bone scintigraphy","volume":"17","author":"Lee","year":"2016","journal-title":"Korean J Radiol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.08.011_bib0092","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdv289","article-title":"Prospective study evaluating the relative sensitivity of 18F-NaF PET\/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design","volume":"26","author":"Gerety","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.08.011_bib0093","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00259-014-2721-y","article-title":"PET\/CT studies of multiple myeloma using 18\u2009F-FDG and 18\u2009F-NaF: comparison of distribution patterns and tracers\u2019 pharmacokinetics","volume":"41","author":"Sachpekidis","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.08.011_bib0094","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00277-015-2410-3","article-title":"Is there any complimentary role of F-18 NaF PET\/CT in detecting of osseous involvement of multiple myeloma? a comparative study for F-18 FDG PET\/CT and F-18 FDG NaF PET\/CT","volume":"94","author":"Ak","year":"2015","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.08.011_bib0095","article-title":"A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET\/CT, 18F-NaF-PET\/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients","volume":"6","author":"Dyrberg","year":"2017","journal-title":"Acta Radiol Open"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0096","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/RLU.0b013e31828da5cc","article-title":"Comparison of 18F fluoride PET\/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma","volume":"38","author":"Chakraborty","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.08.011_bib0097","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MNM.0b013e3283399120","article-title":"The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients","volume":"31","author":"Yen","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0098","series-title":"PET\/CT Imaging","first-page":"109","article-title":"18F-NaF PET\/CT Imaging","author":"Usmani","year":"2022"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0099","series-title":"Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases","first-page":"539","article-title":"18F-NaF PET\/CT in Bone and Joint Diseases","author":"Lee","year":"2017"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.1983.03340010060032","article-title":"Calcification in soft tissues","volume":"250","author":"Stewart","year":"1983","journal-title":"JAMA, J Am Med Assoc"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.08.011_bib0101","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13139-016-0420-2","article-title":"Unusual soft tissue uptake of f-18 sodium fluoride in three patients undergoing F-18 NaF PET\/CT bone scans for prostate cancer","volume":"51","author":"Hawkins","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0102","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/RLU.0b013e3182392441","article-title":"F-18 fluoride uptake in calcified extraosseous metastases from ovarian papillary serous adenocarcinoma","volume":"37","author":"Agrawal","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.semnuclmed.2005.09.002","article-title":"The Role of Fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast","volume":"36","author":"Langsteger","year":"2006","journal-title":"Semin Nucl Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.08.011_bib0104","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.bjc.6605334","article-title":"Imaging metastatic bone disease from carcinoma of the prostate","volume":"101","author":"Messiou","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/radiology.146.2.6294738","article-title":"Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma","volume":"146","author":"Levenson","year":"1983","journal-title":"Radiology"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.08.011_bib0106","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2214\/AJR.05.0225","article-title":"Flare response in 18 F-fluoride ion PET bone scanning","volume":"186","author":"Wade","year":"2006","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.08.011_bib0107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2214\/ajr.142.4.773","article-title":"The flare phenomenon on radionuclide bone scan in metastatic prostate cancer","volume":"142","author":"Pollen","year":"1984","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/0100-3984.2017.0178","article-title":"Is interim 18 f-fluoride PET\/CT a predictor of outcomes after radium-223 therapy?","volume":"52","author":"Etchebehere","year":"2019","journal-title":"Radiol Bras"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1874471011666180629145030","article-title":"Final outcome of 223Ra-therapy and the role of 18F-fluoride-PET in response evaluation in metastatic castration-resistant prostate cancer\u2013a single institution experience","volume":"11","author":"Kairemo","year":"2018","journal-title":"Curr Radiopharm"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0110","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1359\/jbmr.2003.18.12.2206","article-title":"F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management","volume":"18","author":"Hetzel","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0111","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2214\/AJR.13.12158","article-title":"Molecular imaging in oncology: 18 F-sodium fluoride pet imaging of osseous metastatic disease","volume":"203","author":"Mick","year":"2014","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MNM.0b013e32835fcd9d","article-title":"Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?","volume":"34","author":"Ohnona","year":"2013","journal-title":"Nucl Med Commun"},{"issue":"Suppl 1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0113","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.08.011_bib0114","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2967\/jnumed.116.177295","article-title":"Repeatability of quantitative 18 F-NaF PET: a multicenter study","volume":"57","author":"Lin","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0115","article-title":"The value of 18F-NaF PET\/CT in the diagnosis of bone metastases in patients with nasopharyngeal carcinoma using visual and quantitative analyses","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"Suppl 1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0116","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET image acquisition and quantitative data analysis","volume":"50","author":"Boellaard","year":"2009","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.08.011_bib0117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12149-024-01991-9","article-title":"Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review","volume":"39","author":"de Ruiter","year":"2025","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40644-024-00684-w","article-title":"Extracting value from total-body PET\/CT image data - the emerging role of artificial intelligence","volume":"24","author":"Shiyam Sundar","year":"2024","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.08.011_bib0119","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00259-023-06108-4","article-title":"Automated quantification of PET\/CT skeletal tumor burden in prostate cancer using artificial intelligence: the PET index","volume":"50","author":"Lindgren Belal","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0120","first-page":"67","article-title":"Can radiomics signatures and machine learning methods reinforce the revived role of 18F-NaF in metastatic bone disease?","volume":"14","author":"Elahmadawy","year":"2026","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2026.08.011_bib0121","doi-asserted-by":"crossref","unstructured":"Yan Q., Yan X., Yang X., Li S., Song J. The use of PET\/MRI in radiotherapy. insights imaging. 2024;15(1):63. doi:10.1186\/s13244-024-01627-6","DOI":"10.1186\/s13244-024-01627-6"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.08.011_bib0122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13139-016-0393-1","article-title":"PET\/MRI: technical challenges and recent advances","volume":"50","author":"Jung","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.08.011_bib0123","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.semnuclmed.2023.11.005","article-title":"SPECT\/CT, PET\/CT, and PET\/MRI for response assessment of bone metastases","volume":"54","author":"Zamani-Siahkali","year":"2024","journal-title":"Semin Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:02:11Z","timestamp":1794780131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0001299826001819"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.08.011","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of 18F-fluoride PET in bone metastases: An overview","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}